From Curetoday
Immunotherapy combinations are showing potential for treating patients who have renal cell carcinoma (RCC), according to Robert J. Motzer, M.D., a medical oncologist at Memorial Sloan Kettering Cancer Center. “I am quite optimistic that these combinations will change our approach to kidney cancer in the first-line setting for years to come,” says Motzer.
Read the full article here.
